Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.

Detalles Bibliográficos
Autores principales: Fadavi, Pedram, Arefpour, Amir Mohammad, Hariri, Ramyar, Vasheghani, Maryam, Garousi, Maryam, Taghizadeh‐Hesary, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548816/
https://www.ncbi.nlm.nih.gov/pubmed/34745616
http://dx.doi.org/10.1002/ccr3.4993
_version_ 1784590662111330304
author Fadavi, Pedram
Arefpour, Amir Mohammad
Hariri, Ramyar
Vasheghani, Maryam
Garousi, Maryam
Taghizadeh‐Hesary, Farzad
author_facet Fadavi, Pedram
Arefpour, Amir Mohammad
Hariri, Ramyar
Vasheghani, Maryam
Garousi, Maryam
Taghizadeh‐Hesary, Farzad
author_sort Fadavi, Pedram
collection PubMed
description Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.
format Online
Article
Text
id pubmed-8548816
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85488162021-11-04 Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review Fadavi, Pedram Arefpour, Amir Mohammad Hariri, Ramyar Vasheghani, Maryam Garousi, Maryam Taghizadeh‐Hesary, Farzad Clin Case Rep Case Report Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts. John Wiley and Sons Inc. 2021-10-26 /pmc/articles/PMC8548816/ /pubmed/34745616 http://dx.doi.org/10.1002/ccr3.4993 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Fadavi, Pedram
Arefpour, Amir Mohammad
Hariri, Ramyar
Vasheghani, Maryam
Garousi, Maryam
Taghizadeh‐Hesary, Farzad
Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_full Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_fullStr Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_full_unstemmed Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_short Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_sort dramatic response of aneurysmal bone cyst to denosumab: case report and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548816/
https://www.ncbi.nlm.nih.gov/pubmed/34745616
http://dx.doi.org/10.1002/ccr3.4993
work_keys_str_mv AT fadavipedram dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT arefpouramirmohammad dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT haririramyar dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT vasheghanimaryam dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT garousimaryam dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT taghizadehhesaryfarzad dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview

Ejemplares similares